tirzepatide and svt (ZEPBOUND) Approved for Chronic Weight Management in Adults with Obesity ✨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or Tirzepatide reduces food intake and

Just: Lose weight. So yeah, it makes sense that more and more people are looking at GLP-1s as a fertility tool even if the science is still evolving

Tirzepatide is administered subcutaneously in the abdomen, thigh, or upper arm (upper arm injections should be administered by a caregiver, not self-administered)

Patients with hypertension should receive appropriate first-line antihypertensive therapy according to NICE hypertension guidelines (NG136), which recommend ACE inhibitors, angiotensin receptor blockers, calcium channel blockers, or thiazide-like diuretics as initial treatment depending on age, ethnicity, and comorbidities

"A Retrospective Comparative Analysis of Cutaneous Adverse Reactions in GLP-1 Agonist Therapies"